Blueberries Medical Co.

What Blueberries Medical Co. does

Blueberries Medical Co. is a Colombia-based producer of standardized bioactive ingredients serving the pharmaceutical, advanced cosmetics, and nutraceutical industries. The company transforms biological complexity into reproducible, traceable, and auditable bioactive inputs, emphasizing batch-to-batch consistency, end-to-end traceability, and a Technical Evidence Pack that supports client homologation and audit processes. It operates cGMP-certified productive platforms across more than 3,100 m² of operative facilities, with a documented track record of five years of continuous fabrication with zero deviations and regulatory presence in seven Latin American and international markets.

The company offers a core portfolio of bioactive ingredients, a Technical Evidence Pack of structured documentation and analytical certificates, and custom development services for co-creation and scaling of exclusive bioactives. It is positioned as a technical partner within the Terraflos ecosystem, leveraging shared infrastructure, regulatory coverage, and a B2B channel-partner go-to-market focused on regulated industries. The business model centers on one-time project and supply agreements with regulated formulators, with pricing conducted via direct inquiry rather than public disclosure.

The company was founded in 2013 and is headquartered in Bogotá, Colombia, with 51–100 employees. It is led by Camilo Villalba (CEO and co-founder) and Thomas P. Rodríguez (CFO). The firm has raised approximately C$2.96M across three funding rounds (July 2020, December 2023, March 2025) led by parent company Terraflos Inc., including a C$2M private placement in December 2023 with strategic partner Nutripharma. It acquired BBV Labs in December 2020. The 2023 funding is earmarked for debt repayment, operations expansion, new product launches, and geographic expansion into Argentina, Mexico, and Brazil.

Name

Blueberries Medical Co.

Legal name

Blueberries Medical Co.

Website

https://blueberriesmed.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

51–100 employees

Short description

Blueberries Medical Co. is a Colombia-based B2B supplier of standardized bioactive ingredients for the pharmaceutical, advanced cosmetics, and nutraceutical industries, operating cGMP facilities within the Terraflos ecosystem and serving regulated formulators across Latin America.

Ownership category

akta.pro rank

Product category

Bioactive Ingredients Manufacturing

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts) (AFAJAKAD)

akta.pro secondary industry

Natural Extracts & Botanical Concentrates for Beverages (herbal, spice, aromatic extracts) (AFAFAGAJ)

Keywords

• Standardized bioactives
• Pharmaceutical ingredients
• Cosmetic ingredients
• Nutraceutical ingredients
• CGMP manufacturing

Headquarters

HQ city

Bogotá

HQ country

Colombia

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure

Revenue model

1. Bioactive Ingredients: Sale of standardized bioactive ingredients for pharmaceutical, cosmetic, and nutraceutical formulations
2. Private Placement Funding: C$2 million non-brokered private placement for debt repayment, operations expansion, and new product launch

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Blueberries Medical Co. manufactures and supplies standardized bioactive ingredients for pharmaceutical, advanced cosmetic, and nutraceutical formulations, with strict batch-to-batch consistency, end-to-end traceability, and audit-ready documentation. The portfolio is supported by a Technical Evidence Pack for regulatory validation and by custom co-development services for exclusive bioactives.

Product overview

Blueberries Medical Co. is a technology-enabled provider of standardized bioactive ingredients operating within the Terraflos® ecosystem. The company offers a core portfolio of bioactive ingredients for the pharmaceutical, cosmetic, and nutraceutical industries, complemented by a Technical Evidence Pack for regulatory documentation and custom development services for co-creation and scaling of exclusive bioactives. Their value proposition centers on batch-to-batch consistency, end-to-end traceability, and audit-ready documentation for regulated industries.

Differentiator

Problem solved

Functional benefit

Products and services

• Bioactivos (Bioactive Ingredients) Standardized bioactive ingredients produced under cGMP conditions for pharmaceutical, advanced cosmetic, and nutraceutical formulations, with batch-to-batch consistency and end-to-end traceability from origin to delivery.
• Advanced Formulation Portfolio (Portfolio de Ingredientes)
• Technical Evidence Pack (Soporte Documental Técnico)
• Custom Development Services (Desarrollos a Medida)

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• NutripharmacoreStrategic or Co-development Partner · 15 December 2023Strategic partnership with Nutripharma announced as part of the C$2 million private placement funding. Partnership supports expansion plans in Latin American markets including Argentina, Mexico, and Brazil.
• TerrafloscoreStrategic or Co-development PartnerBlueberries is a company of Terraflos ecosystem. Operates under Terraflos brand providing certainty and rigor for scaling innovations. Benefits include frictionless onboarding, immediate documentary responses, and scalable supply. Terraflos enables operational governance and technical integrity for regulatory validations.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Kemin Industries: Kemin supplies specialty ingredients for human and animal nutrition, cosmetics, and pharma, including botanical extracts. Comparable as a broader specialty ingredient platform targeting regulated industries like Blueberries.
• Naturex (Givaudan): Naturex, now part of Givaudan, supplies a broad portfolio of natural specialty ingredients across food, nutrition, and personal care. It is a much larger incumbent in the standardized botanical space and overlaps Blueberries' nutraceutical and cosmetic customer base.
• Frutarom (IFF): Frutarom, now part of International Flavors & Fragrances, is a global ingredients platform with significant botanical/natural extracts for nutraceutical and personal care. Competes broadly with Blueberries in standardized plant-based bioactive ingredients.

Direct peers

• Indena: Indena is a global leader in standardized botanical extracts and active pharmaceutical ingredients derived from plants, supplying pharma, cosmetic, and nutraceutical customers with documented quality. Blueberries competes for the same qualified-supplier lists, especially in Latin America where Indena seeks local partners.
• Euromed: Euromed produces standardized botanical extracts for pharmaceutical and nutraceutical applications with full traceability and analytical documentation, mirroring Blueberries' cGMP-ready, traceable bioactive platform. Both target the same B2B regulated-industry buyers.
• Martin Bauer Group: Martin Bauer is one of the world's largest botanical extract suppliers, serving beverages, nutrition, and pharma with high-quality plant-based ingredients. Comparable to Blueberries in standardized botanical inputs and regulated-customer focus.
• Sabinsa: Sabinsa is a long-established supplier of standardized botanical extracts and nutraceutical ingredients with proprietary science and global regulatory dossiers. It directly overlaps Blueberries' value proposition of standardized, documented bioactives for formulators.
• Finzelberg: Finzelberg specializes in standardized phytopharmaceuticals and botanical extracts for pharmaceutical and nutraceutical uses, with regulatory documentation and traceability. Direct peer in the medicinal botanical/extract manufacturing space.

Emerging players

• Asoex Life Sciences (Pharmactive): Pharmactive is a mid-sized European supplier of botanical extracts for pharma, nutraceutical, and personal care customers, focused on documented, premium-grade ingredients. Comparable scale and positioning to Blueberries.
• Applied Food Sciences: Applied Food Sciences produces standardized botanical extracts and natural ingredients for functional beverages, supplements, and personal care. Similar B2B standardized-bioactives proposition targeting regulated buyer segments.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/BlueberriesMed

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds4 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Blueberries Medical Co.